Miguel Ángel López Nevot-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

    International Journal of Molecular Sciences, Vol. 24, Núm. 9, pp. 8005

2022

  1. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal